Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gaspar

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Molecular Pharmacology|May 19, 2006
Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expressionAnn M Kapoun, Nicholas J Gaspar, Ying Wang, et al.
Plos Biology|April 10, 2025
A nonenzymatic dependency on inositol-requiring enzyme 1 controls cancer cell cycle progression and tumor growthIratxe Zuazo-Gaztelu, David Lawrence, Ioanna Oikonomidi, et al.
Biomedicines|February 24, 2024
L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to ImmunotherapyBruna Victorasso Jardim-Perassi, Pietro Irrera, Oluwaseyi E Oluwatola, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
L-DOS47 enhances response to immunotherapy in pancreatic cancer tumorBruna Victorasso Jardim-Perassi, Pietro Irrera, Dominique Abrahams, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Molecular Pharmacology|May 19, 2006
Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expressionAnn M Kapoun, Nicholas J Gaspar, Ying Wang, et al.
Plos Biology|April 10, 2025
A nonenzymatic dependency on inositol-requiring enzyme 1 controls cancer cell cycle progression and tumor growthIratxe Zuazo-Gaztelu, David Lawrence, Ioanna Oikonomidi, et al.
Biomedicines|February 24, 2024
L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to ImmunotherapyBruna Victorasso Jardim-Perassi, Pietro Irrera, Oluwaseyi E Oluwatola, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
L-DOS47 enhances response to immunotherapy in pancreatic cancer tumorBruna Victorasso Jardim-Perassi, Pietro Irrera, Dominique Abrahams, et al.
Pageof 15